Sky Labs Unveils Support for the AHA's Clinical Hypertension Research Award

Sky Labs Unveils Support for AHA's Clinical Hypertension Research Award

In a significant move for the field of cardiovascular health, Sky Labs has pledged its backing to the Established Investigator Award for Clinical Hypertension, initiated by the American Heart Association (AHA). This initiative was made public on March 12, 2026, following a formal Memorandum of Understanding (MoU) between Sky Labs and AHA signed last September. The partnership aims to advance global research efforts in hypertension, which is a critical public health issue affecting millions worldwide.

Funding Details and Impact on Research

Sky Labs will contribute approximately $90,000, which will support three distinguished researchers focusing on hypertension from 2026 to 2028. This funding encompasses annual honorariums for the chosen investigators as well as essential costs related to the award's operation. To qualify for the award, candidates must be members of the AHA’s Scientific Council on Hypertension, ensuring that the recognized individuals are at the forefront of hypertension research.

Jack Byunghwan Lee, CEO of Sky Labs, expressed his enthusiasm regarding this support, stating, "We are deeply honored to contribute to world-class hypertension research outcomes through our support for the American Heart Association. Our commitment to intensifying clinical research aims to validate effective blood pressure management solutions, supplemented by our ongoing research and development efforts."

Sky Labs: Innovating in Healthcare

Founded in September 2015, Sky Labs is at the forefront of healthcare innovation, particularly in the realm of chronic disease management. One of their flagship products, CART, is the world’s first medical-grade ring-type wearable blood pressure monitor. Since its start, Sky Labs has expanded its expertise, and in 2023, they received medical device approval for CART BP pro, designed for continuous 24-hour blood pressure monitoring. In 2024, this device was recognized under the existing medical procedure for ambulatory blood pressure monitoring.

Moreover, in September 2025, they launched the CART BP, a consumer-oriented blood pressure monitor, making it accessible through their online channels. These innovative products mark a significant leap in how individuals can manage chronic diseases like hypertension in their daily lives.

Future Directions in Hypertension Research

The collaboration with the AHA is indicative of Sky Labs’ efforts to bolster hypertension research significantly. As the partnership unfolds, the awards will not only incentivize outstanding scientific contributions but also potentially lead to breakthroughs in managing and treating hypertension. The urgency for advancements in hypertension research is apparent, as it is a leading risk factor for cardiovascular diseases and stroke.

By backing this award, Sky Labs aims to play a pivotal role in not just supporting research but also inspiring future generations of researchers in this essential field. The firm’s commitment to clinical excellence and innovation in medical devices positions it as a key player in shaping the future of health technology.

More details about their cutting-edge products and initiatives can be found on their official website at Sky Labs. This partnership marks a new chapter in the battle against hypertension, reflecting hope for improved healthcare outcomes worldwide.

Conclusion

Sky Labs’ collaboration with the American Heart Association represents a significant enhancement in the arena of hypertension research funding. By investing in this worthy cause, both organizations are making strides toward mitigating a pressing health issue and contributing to greater public health outcomes through collaborative research efforts. As Sky Labs continues to innovate, the impact of their contributions will surely resonate across the medical community and beyond.